The study said that people who received at least two doses of the COVID-19 vaccination compared to those who received none experienced 8 of the 10...
The world's first intranasal COVID-19 vaccine, iNCOVACC, received approval from DCGI under restricted use in emergency situations for ages 18 and above
The research, published in the New England Journal of Medicine, analysed the probability of vaccinated people becoming infected with the omicron subvariant BA.5
A total of 15.66 crore precaution coronavirus vaccine doses have been given till now with 10.39 crore doses being administered since July 15 up till now
The Serum Institute of India in collaboration with Novavax is working on a vaccine specific to BA.5, a sub-variant of Omicron
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light to the Moderna vaccine as a “sharpened tool” against the novel coronavirus after...
The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin
Taking to Twitter, Bill Gates expressed gratitude for the continued partnership with Indian vaccine manufacturers and the government for mitigating the impact of COVID-19
The research published in the 'Proceedings of the National Academy of Sciences' (PNAS) explains how vaccines create a longer immunity than antibodies from infection, and therefore...
India launches first COVID-19 vaccine for animals - Anocovax. Here are the things you should know
The scientists from multiple institutions were examining Omicron's BA.4 and BA.5 sublineages - which the World Health Organization last month added to its monitoring list.
Boosters are also important because evidence suggests that inactivated vaccines like Coronavac offer lower protection than the new mRNA technology vaccines from Pfizer and Moderna